“PO86 | Emicizumab in Patients With Moderate Hemophilia A and Severe Bleeding Phenotype: Single-Center Real-World Experience: A.L. Faccini, M. Biglietto, S. Sorella, E. Crisanti, M. Antonacci, R. Mormile, R. Ciciani, E. Baldacci, C. Santoro, S. Ligia | Hematology, Department of Translational and Precision Medicine Sapienza University of Roma, Italy”. Bleeding, Thrombosis and Vascular Biology, vol. 4, no. s1, Aug. 2025, https://doi.org/10.4081/btvb.2025.355.